Johnson & Johnson has temporarily paused further dosing in all COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant. Read more...
The CoVIg-19 Plasma Alliance, a collaboration of plasma companies supported by organizations outside the plasma industry, confirmed patients are now being enrolled in the Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) Phase 3 clinical trial sponsored by the NIAID, part of the NIH. Read more...
Eli Lilly and Company and Incyte are sharing additional data showing baricitinib in combination with remdesivir reduced time to recovery and improved clinical outcomes for patients with COVID-19 infection compared with remdesivir. Read more...
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.